Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initiation of Methylene Blue for Septic Shock in Adults
NCT06532240Phase 3Completed
- Sponsor
- Subei People's Hospital
- Start
- Aug 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in septic shock, sponsored by Subei People's Hospital. Started Aug 2024; status: completed.
02
Drugs
methylene blue
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06532240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06532240.